nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2026, 05, v.43 61-68
苗药黑骨藤追风活络胶囊联合西药治疗类风湿关节炎安全性与有效性的Meta分析
基金项目(Foundation): 贵州省苗医药全省重点实验室(黔科合平台ZSYS(2025)018)
邮箱(Email):
DOI:
发布时间: 2026-09-30
出版时间: 2026-09-30
移动端阅读
摘要:

目的 本研究旨在系统评价黑骨藤追风活络胶囊联合西药治疗类风湿关节炎的疗效与安全性,为临床应用提供依据。方法 通过检索中国知网、万方数据库、中文科技期刊数据库、SinoMed、PubMed及Web of Science,收集截至2025年12月发表的相关随机对照试验(RCTs)。两名研究者对文献进行筛选与数据提取,并利用Cochrane偏倚风险评估工具对纳入研究的方法学质量进行评价,采用RevMan 5.4软件对数据进行Meta分析。结果 最终纳入5篇RCTs,涉及362例类风湿关节炎患者,其中试验组180例,对照组182例。Meta分析结果显示,黑骨藤追风活络胶囊联合西药总有效率显著高于单独使用西药(RR=1.21,95%CI:1.10~1.33,P=0.0001),但试验组不良反应与对照组差异无统计学意义(RR=0.29,95%CI:0.12~0.70,P=0.51)。结论 黑骨藤追风活络胶囊联合西药优于单独使用西药,能提高临床总有效率,保障临床安全。但因临床研究数量较少,且质量有待提高,未来可规范临床试验过程,提高证据质量,为临床应用提供证据支持。

Abstract:

Objective To systematically evaluate the efficacy and safety of Heiguteng Zhuifeng Huoluo Capsules combined with Western medicine in the treatment of rheumatoid arthritis(RA) and to provide evidence for their clinical use.Methods China National Knowledge Infrastructure(CNKI), Wanfang Data, Chinese Science and Technology Journal Database(VIP), SinoMed, PubMed, and Web of Science were systematically searched for relevant randomized controlled trials(RCTs) published through December 2025. Two reviewers independently screened the literature and extracted data. The methodological quality of the included studies was assessed using the Cochrane risk-of-bias tool. Meta-analysis was performed using RevMan 5.4.Results Five RCTs involving 362 patients with RA were included, with 180 patients in the intervention group and 182 in the control group. Meta-analysis showed that Heiguteng Zhuifeng Huoluo Capsules combined with Western medicine resulted in a significantly higher overall response rate than Western medicine alone(RR=1.21, 95% CI: 1.10-1.33, P=0.0001). For adverse reactions, the reported pooled effect estimate was RR=0.29(95% CI: 0.12-0.70, P=0.51), with no statistically significant difference reported between the intervention and control groups.Conclusion Heiguteng Zhuifeng Huoluo Capsules combined with Western medicine may improve the overall clinical response in patients with RA compared with Western medicine alone. However, given the limited number of available studies and concerns regarding their methodological quality, these findings should be interpreted with caution. Further well-designed, high-quality RCTs are warranted to strengthen the evidence base for clinical application.

参考文献

[1] 刘杏,李鑫,夏宇,等.桂枝芍药知母汤联合化学药物治疗类风湿关节炎临床疗效的Meta分析附视频[J].世界中医药,2024,19(22):3479-3492.

[2] Weyand C M,Goronzy J J.The immunology of rheumatoid arthritis[J].Nature Immunology,2021,22(1):10-18.

[3] Molendijk M,Hazes J M,Lubberts E.From patients with arthralgia,pre-RA and recently diagnosed RA:what is the current status of understanding RA pathogenesis?[J].RMD Open,2018,4(1):e000256.

[4] Mu K L,Li L,Chen Y,et al.Analysis of Chemical Constituents of Miao Ethnomedicine Heiguteng Zhuifeng Huoluo Capsule (HZFC) and the Discovery of Active Substances in the Treatment of Rheumatoid Arthritis[J].ACS omega,2024,9(9):10860-10874.

[5] Zhao T,Wei Y,Zhu Y,et al.Gut microbiota and rheumatoid arthritis:From pathogenesis to novel therapeutic opportunities[J].Frontiers in Immunology,2022,13:1007165.

[6] 李磊.非甾体抗炎药治疗风湿性关节炎疗效及不良反应[J].临床合理用药杂志,2019,12(4):88-89.

[7] 李忠民.抗类风湿疾病药物不良反应研究进展[J].黑龙江医药,2018,31(5):985-987.

[8] 张亚美,赵娟,高青华,等.302例中重度类风湿关节炎患者接受阿达木单抗治疗后生存质量的调查研究[J].中国药物应用与监测,2015,12(2):120-123.

[9] 董元凤,董春花.黑骨藤追风活络胶囊联合甲氨蝶呤治疗类风湿性关节炎的疗效与安全性分析[J].基层医学论坛,2019,23(23):3267-3269.

[10] 庞稳泰,王虎城,杨丰文,等.芪苈强心胶囊治疗慢性心力衰竭系统评价的再评价[J].天津中医药,2019,36(11):1088-1093.

[11] 张居文,刘娟,于凡雅,等.十味龙胆花颗粒/胶囊治疗支气管炎有效性与安全性的系统评价与Meta分析[J].中国中药杂志,2026,51(3):880-889.

[12] 古金华,吴娅琳,赵平.黑骨藤追风活络胶囊联合甲氨蝶呤治疗类风湿关节炎的临床分析[J].中国医药指南,2018,16(20):219-220.

[13] 曹彩金,吴志颖,陈正,等.黑骨藤追风活络胶囊联合甲氨蝶呤片治疗类风湿关节炎的临床观察[J].江西医药,2020,55(6):723-726.

[14] 王和鸣,葛继荣,陈治英.黑骨藤追风活络胶囊治疗痹病的临床研究 [J].中国中医骨伤科,1999,(2):14-16.

[15] 王可博,郑秀华,黄培凤.热补针法结合黑骨藤追风活络胶囊治疗风寒湿痹型类风湿关节炎临床研究[J].新中医,2020,52(2):125-129.

[16] 蒋太白,赖陈岑,余玲,等.基于网络药理学和分子对接探究苗药千把刀改善类风湿关节炎的作用机制[J].微量元素与健康研究,2026,43(1):12-21.

[17] 何畑林,刘育辰,刘刚.苗药黑骨藤追风活络胶囊研究进展及质量标志物预测分析[J].亚太传统医药,2023,19(6):86-91.

[18] 罗进芳,何吉,喻杨,等.黑骨藤追风活络胶囊调节NF-κB/STAT3/mPGES-1信号通路改善胶原诱导性关节炎的作用研究[J].贵州科学,2024,42(3):52-56.

[19] 罗进芳,何吉,乐岚,等.黑骨藤追风活络胶囊调节mPGES-1改善胶原诱导性关节炎的作用研究[J].医学信息,2024,37(20):57-61.

[20] Zhao X X,Peng C,Zhang H,et al.Sinomenium acutum:a review of chemistry,pharmacology,pharmacokinetics,and clinical use[J].Pharmaceutical Biology,2012,50(8):1053-1061.

[21] 陈舒茵,梁国成,秦辛.青风藤的化学成分与药理研究现状[J].亚太传统医药,2022,18(3):207-212.

[22] 申玥.威灵仙活性成分木兰花碱抗类风湿性关节炎滑膜增生作用机制研究[D].成都:成都大学,2024.

[23] 胡剑威,丁超,吴莹,等.青藤碱及其制剂治疗类风湿性关节炎的研究进展[J].陕西中医药大学学报,2024,47(3):1-7.

[24] Hao T,Yang Y,Li N,et al.Inflammatory mechanism of cerebral ischemia-reperfusion injury with treatment of stepharine in rats[J].Phytomedicine:International Journal of Phytotherapy and Phytopharmacology,2020,79:153353.

[25] 宋莎莎,王永芳,陈毅,等.壬二酸和水杨酸对痤疮丙酸杆菌诱导的细胞炎症因子及TLR4蛋白表达的影响[J].现代药物与临床,2024,39(2):296-303.

[26] 蒋激扬,刘发.腺苷的抗炎作用[J].中国药理学通报,1998.

[27] 孙文娟,龙春芳,龙毅.黑骨藤的化学成分和药效研究进展[J].凯里学院学报,2021,39(3):55-59.

[28] Lee Y H.An overview of meta-analysis for clinicians[J].The Korean Journal of Internal Medicine,2018,33(2):277-283.

基本信息:

中图分类号:R593.22

引用信息:

[1]王妹菊,黄执中,李燕,等.苗药黑骨藤追风活络胶囊联合西药治疗类风湿关节炎安全性与有效性的Meta分析[J].微量元素与健康研究,2026,43(05):61-68.

基金信息:

贵州省苗医药全省重点实验室(黔科合平台ZSYS(2025)018)

发布时间:

2026-09-30

出版时间:

2026-09-30

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文